JPRN-UMIN000026965已完成未知
Phase II clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with glioblastoma. - Phase II clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with glioblastoma.
Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine0 个研究点目标入组 35 人开始时间: 2017年4月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. There is deep-seated active infection. 2,3 There are severe complications including malignant hypertention, cardiac failure, liver cirrhosis, severe DM, severe lung fiblosis, active interstitial pneumonitis.Patients who have complications that are considered inappropriate for the trial. 4. Dependent on total parenteral nutrition(TPN) 5. There are other malignancies. 6. There are hematopoietic stem cell disorders such as myelodisplastic syndorome(MDS) and myeloproliferative disorders (MPD). 7. Post allogeneic hematopoietic stem cell transplantation 8. Pregnant or lactating woman 9. Allergic histry for dacarbazine 10. Responsible doctors judged the patient inappropriate for the trial
研究者
相似试验
尚未招募
1 期
Phase II clinical trial of WT1 peptide-based vaccine for pediatric patients with recurrent malignant gliomaMalignant Glioma DIPGJPRN-UMIN000013258Osaka university graduate school of medicine18
已完成
1 期
Phase I/II clinical trial of WT1 peptide-based vaccine for the patients with malignant tumors.Malignant solid tumors, Malignant lymphoma, Multiple Myeloma, Acute leukemiaJPRN-UMIN000002001Department of Cancer immunotherapy, Osaka University Graduate School of Medicine30
已完成
1 期
Phase 1 & 2 clinical trial using peptide vaccine for VEGFR1 & 2 in combination with S-1 and Cisplatin for patients with advanced gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000005007Osaka University, Graduate School of Medicine, Department of Gastroenterological Surgery30
已完成
1 期
Phase 1 & 2 clinical trial using peptide vaccine for VEGFR1 & 2 in combination with S-1 and Cisplatin for patients with advanced gastric cancer (HLA-A*0201)JPRN-UMIN000005345Osaka University, Graduate School of Medicine, Department of Gastroenterological Surgery15
已完成
不适用
Phase I/II clinical trial of WT1 peptide vaccine for the children with malignanciesJPRN-UMIN000002990Osaka Medical Center and Research Institute for Maternal and Child Health20